233 related articles for article (PubMed ID: 27588474)
21. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
22. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.
Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S
Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304
[TBL] [Abstract][Full Text] [Related]
23. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
[TBL] [Abstract][Full Text] [Related]
24. IK6 isoform with associated cytogenetic and molecular abnormalities in Chinese patients with Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Yao L; Cen J; Chen S; Shen H; Chen Y; He J; Chen Z
Leuk Lymphoma; 2013 Aug; 54(8):1626-32. PubMed ID: 23150929
[TBL] [Abstract][Full Text] [Related]
25. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
Boer JM; Koenders JE; van der Holt B; Exalto C; Sanders MA; Cornelissen JJ; Valk PJ; den Boer ML; Rijneveld AW
Haematologica; 2015 Jul; 100(7):e261-4. PubMed ID: 25769542
[No Abstract] [Full Text] [Related]
26. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G
Blood; 2008 Nov; 112(9):3847-55. PubMed ID: 18650450
[TBL] [Abstract][Full Text] [Related]
27. Ikaros and tumor suppression in acute lymphoblastic leukemia.
Payne KJ; Dovat S
Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
[TBL] [Abstract][Full Text] [Related]
28. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
29. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
30. A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.
Capece D; Zazzeroni F; Mancarelli MM; Verzella D; Fischietti M; Di Tommaso A; Maccarone R; Plebani S; Di Ianni M; Gulino A; Alesse E
PLoS One; 2013; 8(7):e68080. PubMed ID: 23874502
[TBL] [Abstract][Full Text] [Related]
31. IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cells.
Suzuki K; Ono R; Ohishi K; Masuya M; Kataoka I; Liu B; Nakamori Y; Ino K; Monma F; Hamada H; Kitamura T; Katayama N; Nosaka T
Int J Oncol; 2012 Jan; 40(1):53-62. PubMed ID: 21901249
[TBL] [Abstract][Full Text] [Related]
32. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.
van der Veer A; Waanders E; Pieters R; Willemse ME; Van Reijmersdal SV; Russell LJ; Harrison CJ; Evans WE; van der Velden VH; Hoogerbrugge PM; Van Leeuwen F; Escherich G; Horstmann MA; Mohammadi Khankahdani L; Rizopoulos D; De Groot-Kruseman HA; Sonneveld E; Kuiper RP; Den Boer ML
Blood; 2013 Oct; 122(15):2622-9. PubMed ID: 23974192
[TBL] [Abstract][Full Text] [Related]
33. Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros.
Schjerven H; McLaughlin J; Arenzana TL; Frietze S; Cheng D; Wadsworth SE; Lawson GW; Bensinger SJ; Farnham PJ; Witte ON; Smale ST
Nat Immunol; 2013 Oct; 14(10):1073-83. PubMed ID: 24013668
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
[TBL] [Abstract][Full Text] [Related]
35. Alternative splicing of Ikaros regulates the FUT4/Le
Yi L; Hu Q; Zhou J; Liu Z; Li H
Biochem Biophys Res Commun; 2019 Feb; 510(1):128-134. PubMed ID: 30683310
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
37. Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells.
Chen Z; Xiao Y; Zhang J; Li J; Liu Y; Zhao Y; Ma C; Luo J; Qiu Y; Huang G; Korteweg C; Gu J
PLoS One; 2011; 6(5):e20475. PubMed ID: 21655267
[TBL] [Abstract][Full Text] [Related]
38. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides AP; Dobson SM; Laurenti E; Notta F; Voisin V; Cheng PY; Yuan JS; Guidos CJ; Minden MD; Mullighan CG; Torlakovic E; Dick JE
Leukemia; 2015 Jan; 29(1):177-87. PubMed ID: 24791856
[TBL] [Abstract][Full Text] [Related]
39. Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia.
Reyes-León A; Juárez-Velázquez R; Medrano-Hernández A; Cuenca-Roldán T; Salas-Labadía C; Del Pilar Navarrete-Meneses M; Rivera-Luna R; López-Hernández G; Paredes-Aguilera R; Pérez-Vera P
PLoS One; 2015; 10(7):e0130756. PubMed ID: 26131904
[TBL] [Abstract][Full Text] [Related]
40. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
Trageser D; Iacobucci I; Nahar R; Duy C; von Levetzow G; Klemm L; Park E; Schuh W; Gruber T; Herzog S; Kim YM; Hofmann WK; Li A; Storlazzi CT; Jäck HM; Groffen J; Martinelli G; Heisterkamp N; Jumaa H; Müschen M
J Exp Med; 2009 Aug; 206(8):1739-53. PubMed ID: 19620627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
